Global Guaifenesin (API) Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Guaifenesin (API) Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Guaifenesin is used to relieve chest congestion. Guaifenesin may help control symptoms but does not treat the cause of symptoms or speed recovery. Guaifenesin is in a class of medications called expectorants. It works by thinning the mucus in the air passages to make it easier to cough up the mucus and clear the airways.
Guaifenesin (API) report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Guaifenesin (API) market is projected to reach US$ 98.3 million in 2034, increasing from US$ 75 million in 2022, with the CAGR of 3.9% during the period of 2024 to 2034. Demand from Pharmaceuticals and Others are the major drivers for the industry.
Global Guaifenesin (API) key players include Granules, Synthokem Labs, Haizhou Pharma, Yuan Cheng Group, Stellar Chemical, etc. Global top five manufacturers hold a share about 65%. Asia-Pacific and North America is the largest market, both with a share about 35%, followed by Europe, with a share about 25 percent. In terms of product, Above 99% is the largest segment, with a share about 75%. And in terms of application, the largest application is Pharmaceuticals.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Guaifenesin (API) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Granules
Synthokem Labs
Haizhou Pharma
Yuan Cheng Group
Stellar Chemical
Seven Star Pharma
Gennex Lab
Iwaki Seiyaku
Pan Drugs
Delta Synthetic
Smart Pharm
Segment by Type
98%-99%
Above 99%
Pharmaceuticals
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Guaifenesin (API) market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Guaifenesin (API), product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Guaifenesin (API) industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Guaifenesin (API) in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Guaifenesin (API) introduction, etc. Guaifenesin (API) Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Guaifenesin (API) market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Guaifenesin (API) report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Guaifenesin (API) market is projected to reach US$ 98.3 million in 2034, increasing from US$ 75 million in 2022, with the CAGR of 3.9% during the period of 2024 to 2034. Demand from Pharmaceuticals and Others are the major drivers for the industry.
Global Guaifenesin (API) key players include Granules, Synthokem Labs, Haizhou Pharma, Yuan Cheng Group, Stellar Chemical, etc. Global top five manufacturers hold a share about 65%. Asia-Pacific and North America is the largest market, both with a share about 35%, followed by Europe, with a share about 25 percent. In terms of product, Above 99% is the largest segment, with a share about 75%. And in terms of application, the largest application is Pharmaceuticals.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Guaifenesin (API) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Granules
Synthokem Labs
Haizhou Pharma
Yuan Cheng Group
Stellar Chemical
Seven Star Pharma
Gennex Lab
Iwaki Seiyaku
Pan Drugs
Delta Synthetic
Smart Pharm
Segment by Type
98%-99%
Above 99%
Segment by Application
Pharmaceuticals
Others
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Guaifenesin (API) market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Guaifenesin (API), product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Guaifenesin (API) industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Guaifenesin (API) in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Guaifenesin (API) introduction, etc. Guaifenesin (API) Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Guaifenesin (API) market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices